BDBM50166295 (R)-2-{4-Chloro-3-[1-(6-methoxy-benzo[d]isoxazol-3-yl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid::CHEMBL364894

SMILES: COc1ccc2c(noc2c1)-n1c(C)c(Cc2cc(O[C@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12

InChI Key: InChIKey=QRGIUBNDZNAVAU-OAHLLOKOSA-N

Data: 1 IC50  1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50166295   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166295 ((R)-2-{4-Chloro-3-[1-(6-methoxy-benzo[d]isoxazol-3...) Show SMILES COc1ccc2c(noc2c1)-n1c(C)c(Cc2cc(O[C@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12 |wD:20.22,(29.61,-7.83,;29.61,-6.29,;28.28,-5.52,;28.28,-3.99,;26.95,-3.22,;25.63,-3.99,;24.17,-3.51,;23.28,-4.76,;24.18,-5.99,;25.63,-5.52,;26.95,-6.28,;23.7,-2.06,;24.59,-.82,;26.14,-.82,;23.7,.43,;24.17,1.91,;25.67,2.23,;26.71,1.11,;28.2,1.44,;29.24,.28,;30.75,.6,;31.22,2.06,;31.78,-.54,;31.31,-2.01,;33.29,-.22,;28.68,2.9,;27.65,4.04,;26.15,3.72,;25.11,4.84,;22.23,-.03,;20.89,.74,;19.55,-.05,;18.2,.74,;16.86,-.05,;17.65,-1.38,;15.53,-.84,;16.08,1.3,;19.55,-1.58,;20.89,-2.36,;22.23,-1.58,)| Show InChI InChI=1S/C28H22ClF3N2O6/c1-14-21(11-16-10-18(5-8-23(16)29)38-15(2)27(35)36)22-12-19(39-28(30,31)32)6-9-24(22)34(14)26-20-7-4-17(37-3)13-25(20)40-33-26/h4-10,12-13,15H,11H2,1-3H3,(H,35,36)/t15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of human peroxisome proliferator activated receptor gamma binding				Bioorg Med Chem Lett 15: 2437-40 (2005) Article DOI: 10.1016/j.bmcl.2005.03.092 BindingDB Entry DOI: 10.7270/Q2CF9PM8
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166295 ((R)-2-{4-Chloro-3-[1-(6-methoxy-benzo[d]isoxazol-3...) Show SMILES COc1ccc2c(noc2c1)-n1c(C)c(Cc2cc(O[C@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12 |wD:20.22,(29.61,-7.83,;29.61,-6.29,;28.28,-5.52,;28.28,-3.99,;26.95,-3.22,;25.63,-3.99,;24.17,-3.51,;23.28,-4.76,;24.18,-5.99,;25.63,-5.52,;26.95,-6.28,;23.7,-2.06,;24.59,-.82,;26.14,-.82,;23.7,.43,;24.17,1.91,;25.67,2.23,;26.71,1.11,;28.2,1.44,;29.24,.28,;30.75,.6,;31.22,2.06,;31.78,-.54,;31.31,-2.01,;33.29,-.22,;28.68,2.9,;27.65,4.04,;26.15,3.72,;25.11,4.84,;22.23,-.03,;20.89,.74,;19.55,-.05,;18.2,.74,;16.86,-.05,;17.65,-1.38,;15.53,-.84,;16.08,1.3,;19.55,-1.58,;20.89,-2.36,;22.23,-1.58,)| Show InChI InChI=1S/C28H22ClF3N2O6/c1-14-21(11-16-10-18(5-8-23(16)29)38-15(2)27(35)36)22-12-19(39-28(30,31)32)6-9-24(22)34(14)26-20-7-4-17(37-3)13-25(20)40-33-26/h4-10,12-13,15H,11H2,1-3H3,(H,35,36)/t15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Maximal intrinsic response against peroxisome proliferator activated receptor gamma transactivation				Bioorg Med Chem Lett 15: 2437-40 (2005) Article DOI: 10.1016/j.bmcl.2005.03.092 BindingDB Entry DOI: 10.7270/Q2CF9PM8
					More data for this Ligand-Target Pair